ArticleBMC musculoskeletal disorders2025
Cross-cultural adaptation and the evaluation of psychometric properties of the Sinhala version of the general rehabilitation adherence scale (GRAS-Sin).
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validity and reliability of the Turkish version of the general rehabilitation adherence scale in individuals with osteoarthritis.BMC musculoskeletal disorders · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPhysiotherapy adherence can be defined as an active, voluntary patient involvement in a mutually agreed-upon course of action to achieve a desired preventive or therapeutic outcomes. Nonadherence may result in increased healthcare costs and poor recovery. Therefore, it is crucial to measure physiotherapy adherence to eliminate obstacles and promote adherence. No validated tool exists to measure physiotherapy adherence among Sinhala-speaking patients in Sri Lanka.
methodsThis study aimed to develop a Sinhala version of the General Rehabilitation Adherence Scale (GRAS-Sin). During the first phase, the original version of the GRAS was translated and culturally adapted to the Sinhala language. In the second phase, a cross-sectional survey was conducted among 200 patients who sought physiotherapy treatment for musculoskeletal issues at the National Hospital, Kandy and the Teaching Hospital, Peradeniya, Sri Lanka, to evaluate its psychometric properties. The pre-final version of the questionnaire developed in the first phase was used in the second phase.
resultsThe majority of the respondents were female (71.5%). Most patients (54.5%) showed a high level (20-24 total scores) of physiotherapy adherence. There was an acceptable level of internal consistency (Cronbach's alpha = 0.82) and test-retest reliability (intraclass correlation coefficient = 0.907, p < 0.05). The content validity index of the scale was 0.89. The sampling adequacy was satisfactory (KMO = 0.755, Bartlett's test p < 0.05). Construct validity was measured by exploratory factor analysis, which revealed a 2-factor model with a 73.4% variance. The incremental fit indices, i.e., the normed fit index, comparative fit index and Tucker-Lewis index, were reported to be > 0.95, whereas the absolute fit index of the root mean square of the approximation error was 0.065. These values indicated a good model fit. No floor and 27% ceiling effects were found. There was a significant (X
conclusionThe GRAS-Sin questionnaire is a valid and reliable tool for assessing physiotherapy adherence among Sinhala-speaking patients in Sri Lanka. However, its ceiling effect may limit differentiation at higher adherence levels. Further studies are required to address the limitations of the ceiling effect in the present study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.